NASDAQ
BioNTech SE (BNTX) has a free cash flow growth of -304.34% as of Friday, May 29, 2026. This represents a 2243.31% decrease compared to its 12-month average of -12.99%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.